US 11,928,614 B2
Patient customized therapeutic regimens
Mark J. Zdeblick, Portola Valley, CA (US); Andrew Thompson, Portola Valley, CA (US); and George M. Savage, Portola Valley, CA (US)
Assigned to OTSUKA PHARMACEUTICAL CO., LTD., Tokyo (JP)
Filed by OTSUKA PHARMACEUTICAL CO., LTD., Tokyo (JP)
Filed on Sep. 28, 2017, as Appl. No. 15/719,498.
Application 15/719,498 is a continuation of application No. 14/584,736, filed on Dec. 29, 2014, abandoned.
Application 14/584,736 is a continuation of application No. 12/299,303, granted, now 8,956,287, issued on Feb. 17, 2015, previously published as PCT/US2007/010688, filed on May 2, 2007.
Claims priority of provisional application 60/746,250, filed on May 2, 2006.
Prior Publication US 2018/0089393 A1, Mar. 29, 2018
Int. Cl. G06Q 10/00 (2023.01); A61B 5/00 (2006.01); A61B 5/07 (2006.01); G16H 20/10 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); H01M 8/02 (2016.01); H04B 13/00 (2006.01)
CPC G06Q 10/00 (2013.01) [A61B 5/0002 (2013.01); A61B 5/0028 (2013.01); A61B 5/073 (2013.01); A61B 5/4833 (2013.01); A61B 5/4848 (2013.01); G16H 20/10 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); H01M 8/02 (2013.01); H04B 13/005 (2013.01); H01M 2220/10 (2013.01); Y10S 128/903 (2013.01); Y10S 128/92 (2013.01)] 16 Claims
 
1. A method for customizing a therapeutic regimen for a patient, the method comprising:
generating, by a signal generation element of a first device while inside the patient, actual dosage administration data comprising confirmatory data that a first medical composition associated with a prescribed therapeutic regimen has actually been administered to the patient, wherein the first device is physically associated with the first medical composition, wherein the signal generation element generates the signal by encoding the actual dosage administration data into a conductive signal;
transmitting, by the first device, the conductive signal containing the actual dosage administration data, to a signal receiving device associated with a body of the patient, through an electrical current formed between the first device and the signal receiving device using the body of the patient as a conductive medium;
accessing, by an evaluation module associated with an evaluation computer system, the actual dosage administration data from the signal receiving device;
based on the transmission of the actual dosage administration data from the first device to the signal receiving device, confirming, by the evaluation module, that the first medical composition associated with the prescribed therapeutic regimen has actually been administered to the patient;
receiving, by the evaluation module, supplemental data associated with the patient, wherein the supplemental data comprises physiological parameter data detected from the body of the patient;
assessing, by the evaluation module, the actual dosage administration data and the supplemental data;
generating, by the evaluation module, a recommendation to modify the prescribed therapeutic regimen, the recommendation comprising at least one option that the patient be provided a second device physically associated with a second medical composition different than the first medical composition; and
sending, by the evaluation module, the generated recommendation to a reviewer computer system to implement a modified therapeutic regimen for the patient based on the recommendation.